Public procurement notice: Prior Information Notice Without Call For Competition
Published: 2024-03-07
Region: FR101
Contract type: Services
CPV classification: 73200000 | 85100000: Health services

Technical requirements: Title: Open Market Consultation of PROCURE4HEALTH for the future PreCommercial Procurement of R&D services concerning sustainable personal protection against pathogens
Description: This Prior Information Notice announces the Open Market Consultation conducted by the PROCURE4HEALTH project and provides information about a potential future PreCommercial Procurement (PCP) of R&D services concerning sustainable personal protection against pathogens. PROCURE4HEALTH aims to challenge the market to develop innovation solutions that can operate as an alternative to singleuse facemasks, providing the same level of protection as disposable masks while significantly reducing the environmental footprint. PCP is an approach that allows public procurers to buy R&D from several competing suppliers in parallel, to compare alternative solution approaches, and to identify the best valueformoney solutions that the market can deliver to address their needs. It is split into three phases: solution design, prototype implementation, and validation and demonstration of the solutions. In PCP, there is a riskbenefit sharing under market conditions between the public procurer and the suppliers, and a clear separation between the PCP and the deployment of commercial volumes of endproducts. The PCP procurement is exempted from the WTO Government Procurement Agreement (GPA), the EU public procurement directives and the national laws that implement them. The future PCP will be composed of three phases: Phase 1. Solution design: Phase 1 of the PCP will deal with the design of the solutions and verification of their technical and economic feasibility based on functional requirements. It will be implemented according to the tender documents in compliance with the procurement principles and the PCP methodology. Several technology providers will be selected for this phase. Phase 2. Prototype implementation: Phase 2 of the PCP concerns the development of the first prototypes of the solutions and testing at the procurers’ premises under controlled conditions. Several technology providers will be selected for this phase. Phase 3. Validation and demonstration of the solutions: Phase 3 of the PCP will deal with testing and validation of the selected solutions in operational environments. It will take place in several Member States. A minimum of 2 operators per challenge will be selected for this phase. The selected operators will retain ownership of the Intellectual Property Rights (IPRs) that they will generate during the PCP and will be able to use them to exploit the full market potential of the developed solutions. This PIN invites all interested technology providers from EU Member States and Associated Countries committed to perform R&D in the EU and/or Associated Countries, regardless of their size or governance structure, to take part in the Open Market Consultation. The Open Market Consultation aims to: (1) Validate the findings of the stateoftheart analysis and the viability of the set of technical and financial provisions. (2) Raise awareness to the industry regarding the upcoming precommercial procurement (PCP). (3) Collect insights from the industry which can be used to fine tune the tender specifications. The market consultation may include one or more events, and a questionnaire to request information from the market. This Prior Information Notice is not a commitment to procure. The contracting authorities involved are not legally bound in any way by the outcome of the market consultation. No advantage or disadvantage will be given to any supplier /group of suppliers to the detriment of others during the market consultation and the subsequent competitive procedure for the award of contracts. The official communication language is English. The Open Market Consultation document will be published on the PROCURE4HEALTH website (www.procure4health.eu). The project has received funding from the Horizon Europe Framework Programme (HORIZON) under grant agreement n. 101057209. However, the European Union will not participate as a contracting authority in the procurement.
Buyers, organizations and resgistration numbers are detailed in "addittional informations" section.